MiR-101 is also involved in the Wnt/MAPK/cadherin signaling pathway, as well as hypertrophic cardiomyopathy (HCM), melanogenesis, the metabotropic glutamate receptor group III pathway and ubiquitin-mediated proteolysis. Here, CDH17 is linked to hypertrophic cardiomyopathy.